A field evaluation of the application of dynamic lighting in living and care facilities for the demented people.
- Conditions
- verstoord dag-nachtritmedementiapsychogeriatric diseases
- Registration Number
- NL-OMON32599
- Lead Sponsor
- VIVRE contactpersoon H.J.H.M.M.verheesen MHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
diagnostisized with psychogeriatric disease
living in Klevarie with indication ZZP5 or ZZP7
Exclusion Criteria
diagnosis was set before the age of 70
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>activity measurement<br /><br>change in circadian rhythm</p><br>
- Secondary Outcome Measures
Name Time Method <p>improvement of quality of life<br /><br>reduction of behavioral disturbances</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does dynamic lighting modulate in NL-OMON32599 to address circadian rhythm disruption in dementia patients?
How does dynamic lighting compare to cholinesterase inhibitors in managing circadian rhythm disorders among dementia residents?
Which biomarkers predict response to dynamic lighting interventions in patients with disrupted circadian rhythms and dementia?
What are the potential adverse effects of dynamic lighting in psychogeriatric care settings and how are they managed?
Are there synergistic effects when combining dynamic lighting with melatonin supplementation for dementia-related circadian rhythm disorders?